High Poly(ADP-Ribose) Polymerase Expression Does Relate to Poor Survival in Solid Cancers: A Systematic Review and Meta-Analysis
Poly (ADP-ribose) polymerase (PARP) is a DNA damage repair protein, and its inhibitors have shown promising results in clinical trials. The prognostic significance of PARP is inconsistent in studies of various cancers. In the present study, we conducted a systematic review and meta-analysis to revea...
Guardado en:
Autores principales: | Nishant Thakur, Kwangil Yim, Jamshid Abdul-Ghafar, Kyung Jin Seo, Yosep Chong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ebee618a9b5a4398b4aef6553bb27b11 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PARP Inhibitors in Combination with Radiotherapy: To Do or Not to Do?
por: Amelia Barcellini, et al.
Publicado: (2021) -
Pharmacological Poly (ADP-Ribose) Polymerase Inhibitors Decrease Mycobacterium tuberculosis Survival in Human Macrophages
por: Cassandra L. R. van Doorn, et al.
Publicado: (2021) -
Role of poly (ADP-ribose) polymerase-1 and cytokines in acute renal injury in elderly Chinese patients with diabetes mellitus
por: Cao L, et al.
Publicado: (2017) -
Lipoic Acid Decreases the Expression of Poly ADP-Ribose Polymerase and Inhibits Apoptosis in Diabetic Rats
por: Chen J, et al.
Publicado: (2020) -
Update on Poly ADP-Ribose Polymerase Inhibitors in Ovarian Cancer With Non-BRCA Mutations
por: Qin Xu, et al.
Publicado: (2021)